Some spike mutations of the new variant of concern B.1.1.529 were observed in patients receiving Molnupiravir: del143, del144, del145, and P681H.
Two of them (del143 and del145) were not in any prior VOC, and the other two were only in Alpha.
Molnupiravir has been authorized in the UK. Some countries started using it without authorizing. Also, significant quantities of Molnupiravir have been manufactured and shipped all over the world.
Work in progress
via Science Defies Politics
November 26, 2021 at 07:42PM
Iowa Climate Science Education 